FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

320374005: Aminophylline 350mg modified release tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    463227018 Aminophylline 350mg m/r tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    2709909013 Aminophylline 350mg modified release tablet (product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    2765284013 Aminophylline 350mg modified release tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    48604601000001117 Aminophylline hydrate 350mg modified-release tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Aminophylline 350mg modified release tablet Is a Product containing aminophylline in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Is a Aminophylline m/r tablet false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has active ingredient Smooth muscle relaxant false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has active ingredient Aminophylline false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has active ingredient Substance with phosphodiesterase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has active ingredient Xanthine false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has active ingredient Musculoskeletal system agent false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has active ingredient Aminophylline hydrate false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Aminophylline 350mg modified release tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Aminophylline 350mg m/r tablet - product Is a False Aminophylline 350mg modified release tablet Inferred relationship Existential restriction modifier
    Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) Is a False Aminophylline 350mg modified release tablet Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablets 56 tablet Is pack of False Aminophylline 350mg modified release tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start